RBC Life Science and Technology Fund

You are on: FUND INDIVIDUAL page

Select Series:
Select Another Fund:

Marcello Montanari

Profile >

Rob Cavallo

Profile >

Investment Objective

To provide long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Fund Details

Series: A
Fund Code: RBF274
Load Structure: No Load
Currency: CAD
Inception Date: Jul, 1995
Series A NAV $: 16.38
Series A MER %: 2.15
Adjusted A MER %: 2.09
  • 50% S&P 500 Health Care Index ($C)
  • 50% S&P 500 Information Technology Index ($C)

  • Income Distribution: Annually
    Capital Gains Distribution: Annually
    Sales Status: Open
    Minimum Investment $: 500
    Subsequent Investment $: 25



    Performance Analysis as of  May 31, 2017

    Growth of $10,000

    Returns and Quartile Ranking
    Calendar Returns %

    Trailing Return %

    Portfolio Analysis

    Asset Mix

    Top Ten Holdings
    Top Ten Holdings % Assets
    Apple Inc 10.3
    Alphabet Inc A 8.0
    Microsoft Corp 7.4
    Facebook Inc A 5.1
    Johnson & Johnson 3.9
    Visa Inc Class A 2.7
    Pfizer Inc 2.6
    UnitedHealth Group Inc 2.4
    Cisco Systems Inc 2.1
    Oracle Corp 2.0
    % Assets
    Total % of Top Ten Holdings 46.4
    Total Number of Stock Holdings 114
    Total Number of Bond Holdings 0
    Total Number of Other Holdings 2
    Total Number of Holdings 116
    Equity Style
    P/B Ratio 4.2
    P/E Ratio 22.3
    Avg. Mkt Cap. $Bil 199.1
    Global Equity Sectors
    % Equity
    Information Technology 66.7
    Health Care 33.1
    Telecommunications Services 0.2